I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research, development, and cutting-edge technology in the industry. Today, we’re diving into an exciting partnership that promises to revolutionize traceability in clinical consumables, focusing on
In a landscape where rare diseases often struggle for attention and innovation, cutaneous T-cell lymphoma (CTCL)—encompassing mycosis fungoides (MF) and Sézary syndrome (SS)—stands as a stark reminder of unmet medical needs. With only a small fraction of cancer cases attributed to these conditions,
The pharmaceutical industry stands at a critical crossroads, grappling with the staggering statistic that developing a single new drug can cost upwards of $2.6 billion and take over a decade from discovery to market, pushing the sector to seek groundbreaking solutions. Artificial Intelligence (AI)
In the fast-evolving landscape of biopharmaceutical production, ensuring the consistency of cell culture media stands as a cornerstone for achieving reliable cell growth and high-quality therapeutic products, especially given the complexity of these media formulations. With hundreds of components
Thyroid cancer, recognized as the most prevalent endocrine malignancy and ranking ninth among cancers globally, poses a significant health challenge with its diverse subtypes ranging from the more treatable papillary thyroid carcinoma to the highly aggressive anaplastic thyroid carcinoma, each
Imagine a future where life-saving medications and sustainable agricultural chemicals can be produced without the unpredictability and inefficiencies tied to living cells, a vision that is rapidly becoming reality through the innovative field of cell-free biomanufacturing. This transformative
